Mind + Muscle

technical minds + legal muscle


dig deep

Strategies for Challenging Patents in Pharma and BioPharma In the Wake of the In re NTP Decision

  • 02.03.12
  • Bloomberg BNA's Pharmaceutical Law & Industry Report

In this article, Eric K. Steffe, Eldora L. Ellison and Christopher M. Gallo discuss opportunities for patent challengers in Pharma and BioPharma as a result of the recent In re NTP decision and provide strategies that illustrate how to best utilize these opportunities in patent reexamination proceedings. To read the full article, click on the PDF above.

Related People

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.